`Document Description: TrackOne Request
`
`PTO/AIA/424 (03-14)
`
`CERTIFICATION AND REQUEST FOR PRIORITIZED EXAMINATION
`UNDER 37 CFR 1.102(e) (Page 1 of 1)
`
`I Nonprovisional Application Number (if I
`
`known):
`
`First Named
`Inventor:
`Title of
`Invention:
`
`David PANIAGUA
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`APPLICANT HEREBY CERTIFIES THE FOLLOWING AND REQUESTS PRIORITIZED EXAMINATION FOR
`THE ABOVE-IDENTIFIED APPLICATION.
`
`1. The processing fee set forth in 37 CFR 1.17(i)(1 ), the prioritized examination fee set forth in
`37 CFR 1.17(c), and if not already paid, the publication fee set forth in 37 CFR 1.18(d) have
`been filed with the request. The basic filing fee, search fee, and examination fee are filed with
`the request or have been already been paid. I understand that any required excess claims fees
`or application size fee must be paid for the application.
`
`2.
`
`I understand that the application may not contain, or be amended to contain, more than four
`independent claims, more than thirty total claims, or any multiple dependent claims.
`
`i.
`
`3. The applicable box is checked below:
`I. 0 Original Application (Track One) - Prioritized Examination under§ 1.102(e)(1)
`(a) The application is an original nonprovisional utility application filed under 35 U.S.C. 111 (a).
`This certification and request is being filed with the utility application via EFS-Web.
`---OR---
`(b) The application is an original nonprovisional plant application filed under 35 U.S.C. 111 (a).
`This certification and request is being filed with the plant application in paper.
`
`ii. An executed inventor's oath or declaration under 37 CFR 1.63 or 37 CFR 1.64 for each
`inventor, or the application data sheet meeting the conditions specified in 37 CFR 1.53(f)(3)(i) is
`filed with the application.
`II. 0 Request for Continued Examination - Prioritized Examination under§ 1.102(e)(2)
`i. A request for continued examination has been filed with, or prior to, this form.
`ii.
`If the application is a utility application, this certification and request is being filed via EFS-Web.
`iii. The application is an original nonprovisional utility application filed under 35 U.S.C. 111 (a), or is
`a national stage entry under 35 U.S.C. 371.
`iv. This certification and request is being filed prior to the mailing of a first Office action responsive
`to the request for continued examination.
`v. No prior request for continued examination has been granted prioritized examination status
`under 37 CFR 1.102(e)(2).
`
`Siqnature / Mark L. Yaskanin /
`~p~~~Typed) Mark L. Yaskanin
`
`Date 15 April 2014
`45246
`
`Practitioner
`Reqistration Number
`
`Note: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4(d) for signature requirements and certifications.
`Submit multiole forms if more than one sianature is reauired. *
`
`□ *Total of
`
`forms are submitted.
`
`Medtronic Exhibit 1003
`Medtronic Corevalve v. Colibri Heart Valve
`IPR2020-01454
`Page 00001
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2)
`furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the
`U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or
`patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process and/or examine your submission, which may result in termination of proceedings or abandonment of the
`application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may
`be disclosed to the Department of Justice to determine whether disclosure of these records is required by the
`Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from
`the Member with respect to the subject matter of the record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having
`need for the information in order to perform a contract. Recipients of information shall be required to comply
`with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency's
`responsibility to recommend improvements in records management practices and programs, under authority of
`44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record
`was filed in an application which became abandoned or in which the proceedings were terminated and which
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`Page 2
`
`IPR2020-01454 Page 00002
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`1
`Inventor
`Legal Name
`
`I Remove I
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`David
`PANIAGUA
`Residence Information (Select One) (!) US Residency 0 Non US Residency 0 Active US Military Service
`I State/Province I TX
`I Country of Residence i I US
`City
`Houston
`
`Mailing Address of Inventor:
`
`Address 1
`
`3813 Drummond Street
`
`Address 2
`City
`I Houston
`Postal Code
`
`2
`Inventor
`Legal Name
`
`1 77025
`
`I State/Province
`1 us
`I Country i
`
`I TX
`
`I Remove I
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`R.
`David
`FISH
`Residence Information (Select One) (!) US Residency 0 Non US Residency O Active US Military Service
`I State/Province I TX
`I Country of Residence i I US
`City
`Houston
`
`Mailing Address of Inventor:
`
`Address 1
`
`6349 Vanderbilt Street
`
`Address 2
`City
`I Houston
`Postal Code
`
`3
`Inventor
`Legal Name
`
`I 77005
`
`I State/Province
`I us
`I Country i
`
`I TX
`
`I Remove I
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`Residence Information (Select One) (!) US Residency 0 Non US Residency O Active US Military Service
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00003
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`City I
`
`I State/Province I
`
`I Country of Residence i I
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`City
`
`I
`Postal Code
`
`4
`Inventor
`Legal Name
`
`I
`
`I State/Province
`I Country i
`I
`
`I
`
`I Remove I
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`Residence Information (Select One) (!) US Residency 0 Non US Residency O Active US Military Service
`I State/Province I
`I Country of Residence i I
`City
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`City
`
`I
`Postal Code
`
`5
`Inventor
`Legal Name
`
`I
`
`I State/Province
`I Country i
`I
`
`I
`
`I Remove I
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`Residence Information (Select One) (!) US Residency 0 Non US Residency O Active US Military Service
`I State/Province I
`I Country of Residence i I
`City
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`City
`
`I
`Postal Code
`
`I State/Province
`I Country i
`I
`I
`All Inventors Must Be Listed - Additional Inventor Information blocks may be
`generated within this form by selecting the Add button.
`
`I
`
`I
`
`Add I
`
`Correspondence Information:
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`D An Address is being provided for the correspondence Information of this application.
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00004
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`Customer Number
`
`29880
`
`Email Address
`
`Add Email
`
`!Remove Email!
`
`I
`
`Application Information:
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION
`SYSTEM
`Attorney Docket Number 109978.10104
`
`Title of the Invention
`
`I Small Entity Status Claimed ~
`
`Application Type
`
`Nonprovisional
`
`Subject Matter
`
`Utility
`
`Total Number of Drawing Sheets (if any)
`Filing By Reference:
`Only complete this section when filing an application by reference under 35 U.S.C. 111 (c) and 37 CFR 1.57(a). Do not complete this section if
`application papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information" and "Foreign Priority Information").
`
`I Suggested Figure for Publication (if any) I 8
`
`I 12
`
`For the purposes of a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a).
`
`Application number of the previously
`filed application
`
`Filing date (YYYY-MM-DD)
`
`Intellectual Property Authority or Country i-
`
`Publication Information:
`D Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`Request Not to Publish. I hereby request that the attached application not be published under
`D 35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below. If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`
`(!) Customer Number
`
`Customer Number
`
`29880
`
`I O US Patent Practitioner lo Limited Recognition (37 CFR 11.9)
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00005
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`Domestic Benefit/National Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate National Stage
`entry from a PCT application. Providing this information in the application data sheet constitutes the specific reference required
`by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`When referring to the current application, please leave the application number blank.
`
`Prior Application Status Pending
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`I Remove I
`Filing Date (YYYY-MM-DD)
`
`Continuation of
`
`13675665
`
`Prior Application Status Patented
`
`Application
`Number
`
`Continuity Type
`
`Prior Application
`Number
`
`Filing Date
`(YYYY-MM-DD)
`
`2012-11-13
`I Remove I
`Issue Date
`(YYYY-MM-DD)
`
`Patent Number
`
`13675665
`
`Continuation of
`
`10887688
`
`2004-07-10
`
`8308797
`
`Prior Application Status Abandoned
`
`2012-11-13
`
`I Remove I
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`10887688
`
`Continuation in part of
`
`10037266
`
`2002-01-04
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`I Add I
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55(d). When priority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (POX) ithe information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(h)(1) and (2). Under the POX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority application is filed, within the lime period specified in 37 CFR 1.55(g)(1 ).
`
`Application Number
`
`Country i
`
`Filing Date (YYYY-MM-DD)
`
`Access Codei (if applicable)
`
`I Remove I
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`I Add I
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00006
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`Statement under 37 CFR 1.55 or 1. 78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`□ 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`16, 2013, will be examined under the first inventor to file provisions of the AIA.
`
`Authorization to Permit Access:
`
`~ Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked if the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)-(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date offiling this Authorization.
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00007
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`I Remove I
`
`Applicant 1
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`Clear
`
`I
`lo Joint Inventor
`
`I
`
`lo Legal Representative under 35 U.S.C. 117
`® Assignee
`lo
`0 Person to whom the inventor is obligated to assign.
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Person who shows sufficient proprietary interest
`
`Name of the Deceased or Legally Incapacitated Inventor : I
`
`If the Applicant is an Organization check here.
`
`~
`
`Organization Name
`
`I Calibri Heart Valve LLC
`
`Mailing Address Information:
`
`2150 W. 6th Ave, Unit M
`
`Broomfield
`
`Address 1
`
`Address 2
`
`City
`Country ii us
`
`Phone Number
`
`Email Address
`
`I
`
`State/Province
`
`Postal Code
`
`Fax Number
`
`co
`80020
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`I Add I
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Tille 37 of CFR to
`have an assignment recorded by the Office.
`
`Assignee 1
`
`Complete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`application publication . An assignee-applicant identified in the "Applicant Information" section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assignee is also desired on the
`patent application publication.
`
`If the Assignee or Non-Applicant Assignee is an Organization check here.
`
`EFS Web 2.2.11
`
`I Remove I
`□
`
`IPR2020-01454 Page 00008
`
`
`
`PTO/AIN14 (12-13)
`Approved for use through 01/31/2014. 0MB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid 0MB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`109978.10104
`
`Application Number
`
`Title of Invention
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND IMPLANTATION SYSTEM
`
`Prefix
`
`Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Address 1
`
`Address 2
`
`City
`
`Country i
`
`I
`Phone Number
`
`Email Address
`
`I
`
`State/Province
`
`Postal Code
`
`Fax Number
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`selecting the Add button.
`
`I Add
`
`I
`
`Signature:
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`Remove
`
`Signature
`
`/ Mark L. Yaskanin /
`
`Date (YYYY-MM-DD) 2014-04-15
`
`First Name Mark
`
`I Last Name I Yaskanin
`
`Registration Number
`
`45246
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`I Add I
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of lime you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00009
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P .L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuan
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`9.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.11
`
`IPR2020-01454 Page 00010
`
`
`
`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`Filing Date:
`
`Title of Invention:
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND
`IMPLANTATION SYSTEM
`
`First Named Inventor/Applicant Name:
`
`David PANIAGUA
`
`Filer:
`
`Mark Lauren Yaskanin/Carol Donahue
`
`Attorney Docket Number:
`
`109978.10104
`
`Filed as Small Entity
`
`Track I Prioritized Examination - Non provisional Application under 35 USC 111 (a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USO($)
`
`Basic Filing:
`
`Utility filing Fee (Electronic filing)
`
`Utility Search Fee
`
`Utility Examination Fee
`
`Request for Prioritized Examination
`
`4011
`
`2111
`
`2311
`
`2817
`
`1
`
`1
`
`1
`
`1
`
`70
`
`300
`
`360
`
`70
`
`300
`
`360
`
`2000
`
`2000
`
`Pages:
`
`Claims:
`
`Miscellaneous-Filing:
`
`Petition:
`
`IPR2020-01454 Page 00011
`
`
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USO($)
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance:
`
`Extension-of-Time:
`
`Miscellaneous:
`
`Total in USD ($)
`
`2730
`
`IPR2020-01454 Page 00012
`
`
`
`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`18768381
`
`14253650
`
`International Application Number:
`
`Confirmation Number:
`
`5427
`
`Title of Invention:
`
`PERCUTANEOUS BIOPROSTHETIC HEART VALVE AND A DELIVERY AND
`IMPLANTATION SYSTEM
`
`First Named Inventor/Applicant Name:
`
`David PANIAGUA
`
`Customer Number:
`
`29880
`
`Filer:
`
`Mark Lauren Yaskanin/Carol Donahue
`
`Filer Authorized By:
`
`Mark Lauren Yaskanin
`
`Attorney Docket Number:
`
`109978.10104
`
`Receipt Date:
`
`15-APR-2014
`
`Filing Date:
`
`Time Stamp:
`
`18:23:03
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`Payment Type
`
`Payment was successfully received in RAM
`
`RAM confirmation Number
`
`Deposit Account
`
`Authorized User
`
`yes
`
`Credit Card
`
`$2730
`
`4952
`
`501943
`
`YASKANIN, MARK L.
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`IPR2020-01454 Page 00013
`
`
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size(Bytes)/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(if appl.)
`
`185656
`
`1
`
`Calibri_ 10101 _Application.PDF
`
`yes
`
`33
`
`Multipart Description/PDF files in .zip description
`
`e2953f78621 cfel 2118c40aec760737cad53
`d5c7
`
`Document Description
`
`Start
`
`End
`
`Specification
`
`Claims
`
`Abstract
`
`1
`
`26
`
`33
`
`25
`
`32
`
`33
`
`Warnings:
`
`Information:
`
`2
`
`Drawings-only black and white line
`drawings
`
`Calibri_ 10101 _original_drawin
`gs.PDF
`
`121176
`
`7 cb75a9d3294f0d041d3ad10012088fe235
`89be6
`
`no
`
`12
`
`Warnings:
`
`Information:
`
`3
`
`Calibri_ 10104_Preliminary_Am
`endment.PDF
`
`524571
`
`9c6494590e03b0ffdeb921 d355b5dd1 3ea5
`fa5a9
`
`yes
`
`66
`
`Multipart Description/PDF files in .zip description
`
`Document Description
`
`Start
`
`End
`
`Preliminary Amendment
`
`Specification
`
`Claims
`
`Drawings-only black and white line drawings
`
`Applicant A